Filing Details
- Accession Number:
- 0001144204-14-074864
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-18 21:44:39
- Reporting Period:
- 2014-12-16
- Filing Date:
- 2014-12-18
- Accepted Time:
- 2014-12-18 21:44:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1001316 | Tg Therapeutics Inc. | TGTX | Pharmaceutical Preparations (2834) | 363898269 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1038977 | S Michael Weiss | 3 Columbus Ave, 15Th Floor New York NY 10019 | See Remarks | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-12-16 | 210,618 | $16.44 | 8,120,773 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- In connection with the vesting of 375,000 shares on December 15, 2014, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Weiss' tax withholding obligations. Mr. Weiss had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- Weighted average sales price of sales from 12/16/14 to 12/18/14.
- Includes shares of restricted Common Stock, which vest over various time periods. Includes 33,334 warrants to purchase Common Stock at $2.25, exercisable through December 31, 2016. Finally, also included in Mr. Weiss' beneficial ownership are 4,524,560 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest.